Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment.

Suarez-Trujillo F, Steiner TS, Gisbert JP, Chaparro M

Open source

DOI
10.3389/fimmu.2026.1920203
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1920203,
  title = {Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment.},
  author = {Suarez-Trujillo F and Steiner TS and Gisbert JP and Chaparro M},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1920203},
  url = {https://doi.org/10.3389/fimmu.2026.1920203}
}

RIS

TY  - JOUR
TI  - Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment.
AU  - Suarez-Trujillo F
AU  - Steiner TS
AU  - Gisbert JP
AU  - Chaparro M
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1920203
UR  - https://doi.org/10.3389/fimmu.2026.1920203
ER  - 

APA

F, S., TS, S., JP, G., & M, C. (2026). Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1920203

Source records